Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Analysis of lung cancer-related genetic changes in long-term and low-dose polyhexamethylene guanidine phosphate (PHMG-p) treated human pulmonary alveolar epithelial cells

Fig. 4

Changes in transcriptional expression levels (more than twofold or less than 0.5-fold) in PHMG-p treated HPAEpiCs. (a) Numbers of commonly changed genes are shown in a Venn diagram. Upregulated gene counts are shown in bold and downregulated gene counts are underlined. (b) Upregulated and downregulated genes at short-term treatment (within 10 days) and long-term treatment (within 35 days), respectively

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us